| Application no. and date | 13712567.0 (espacenet) (Federated) (European Patent Register), 20130328 | | Patent/reg. no. and date | DK/EP 2834229, 20170809 | | Publication date | 20150211 | | Priority no. and date | EP 12162852, 20120402 | | EP pub. no. and date |
EP 2834229 20150211 | | Effective date | | | Applicant/owner | Alkahest, Inc., 75 Shoreway Road, Suite D
San Carlos, California 94070, US | | Applicant ref. no. | P020322EPDK1 JOS/Ve | | Inventor | DURAN, Adil, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
SCHMID, Rolf, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K | | Opponent | | | IPC Class | C07D 401/12 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF CCR3-INHIBITORER | | Int. application no. | EP2013056638 | | Int. publication no. | WO2013149926 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
